Antigen presentation subverted: Structure of the human cytomegalovirus protein US2 bound to the class I molecule HLA-A2

被引:123
作者
Gewurz, BE
Gaudet, R
Tortorella, D
Wang, EW
Ploegh, HL [1 ]
Wiley, DC
机构
[1] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[2] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA
[3] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA
关键词
D O I
10.1073/pnas.121172898
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Many persistent viruses have evolved the ability to subvert MHC class I antigen presentation. Indeed, human cytomegalovirus (HCMV) encodes at least four proteins that down-regulate cell-surface expression of class I. The HCMV unique short (US)2 glycoprotein binds newly synthesized class I molecules within the endoplasmic reticulum (ER) and subsequently targets them for proteasomal degradation. We report the crystal structure of US2 bound to the HLA-A2/Tax peptide complex. US2 associates with HLA-AZ at the junction of the peptide-binding region and the (alpha3 domain, a novel binding surface on class I that allows US2 to bind independently of peptide sequence. Mutation of class I heavy chains confirms the importance of this binding site in vivo. Available data on class I-ER chaperone interactions indicate that chaperones would not impede US2 binding. Unexpectedly. the US2 ER-luminal domain forms an Ig-like fold. A US2 structure-based sequence alignment reveals that seven HCMV proteins, at least three of which function in immune evasion, share the same fold as US2. The structure allows design of further experiments to determine how US2 targets class I molecules for degradation.
引用
收藏
页码:6794 / 6799
页数:6
相关论文
共 49 条
  • [1] The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP
    Ahn, K
    Gruhler, A
    Galocha, B
    Jones, TR
    Wiertz, EJHJ
    Ploegh, HL
    Peterson, PA
    Yang, Y
    Fruh, K
    [J]. IMMUNITY, 1997, 6 (05) : 613 - 621
  • [2] Viral mechanisms of immune evasion
    Alcami, A
    Koszinowski, UH
    [J]. IMMUNOLOGY TODAY, 2000, 21 (09): : 447 - 455
  • [3] Beissbarth T, 2000, EUR J IMMUNOL, V30, P1203, DOI 10.1002/(SICI)1521-4141(200004)30:4<1203::AID-IMMU1203>3.0.CO
  • [4] 2-L
  • [5] MHC class I - Subversive gene functions of cytomegalovirus and their regulation by interferons - an intricate balance
    Benz, C
    Hengel, H
    [J]. VIRUS GENES, 2000, 21 (1-2) : 39 - 47
  • [6] BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582
  • [7] Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand
    Boyington, JC
    Motyka, SA
    Schuck, P
    Brooks, AG
    Sun, PD
    [J]. NATURE, 2000, 405 (6786) : 537 - 543
  • [8] Human cytomegalovirus glycoproteins
    Britt, WJ
    Mach, M
    [J]. INTERVIROLOGY, 1996, 39 (5-6) : 401 - 412
  • [9] Novel immunological aspects of CMV-related diseases - Pathogenesis, diagnosis, and therapy - Proceedings of the 2nd Symposium on CMV-Related Immunopathology - September 17-18, 1999, Maastricht, the Netherlands - Preface
    Bruggeman, CA
    Ramon, A
    Scholz, M
    [J]. INTERVIROLOGY, 1999, 42 (5-6) : 277 - 278
  • [10] Crystallography & NMR system:: A new software suite for macromolecular structure determination
    Brunger, AT
    Adams, PD
    Clore, GM
    DeLano, WL
    Gros, P
    Grosse-Kunstleve, RW
    Jiang, JS
    Kuszewski, J
    Nilges, M
    Pannu, NS
    Read, RJ
    Rice, LM
    Simonson, T
    Warren, GL
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 : 905 - 921